| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |